Guidant takes cerebral stent to the US
This article was originally published in Clinica
Executive Summary
The US FDA has given Guidant the green light to market its Neurolink stent system for treating atherosclerosis of cerebral arteries, a condition that if left untreated, can lead to ischaemic stroke.